Regulatory Overview: Non-prescription drugs in Canada: About non-prescription drugs

On this page

Who this is for

Use the information in this page to understand more about how non-prescription drugs (NPDs) are regulated in Canada and to find additional resources on drug authorization requirements and post-authorization obligations.

This information is intended for:

About non-prescription drugs

In Canada, NPDs are regulated under the Food and Drugs Act (FDA) and the Food and Drug Regulations (FDR), by demonstrating they are safe to use and the benefits outweigh the risks to people in Canada. Before a drug can be sold, it must be assigned a Drug Identification Number (DIN), and in some cases it must also be issued a Notice of Compliance (NOC). When a NPD holds a valid DIN which is displayed on the product's label, that means it has been authorized for sale in Canada. All authorized NPDs in Canada are listed on Health Canada's Drug Product Database. Please also note that a Drug Establishment License (DEL) is required to perform certain activities related to drugs (e.g., importation).

In July 2025, the Government of Canada launched a Red Tape Review that called on departments and agencies to review their regulations in order to reduce regulatory burden for industry and government while providing oversight that is proportionate to risk. Health Canada is planning to make changes in the future that will increase flexibility in requirements and facilitate easier market access in Canada.

For more information :

Determining if a product is a non-prescription drug

Non-prescription drugs are available to consumers without a prescription from a healthcare professional. They are generally available for self-selection, but could also be recommended by a healthcare professional, or be available behind the counter in pharmacies. Although Health Canada determines if a drug requires a prescription, provinces and territories can further restrict how a drug is sold in their province or territory such as requiring an NPD to be sold behind the counter or to require a prescription for the drug instead. NPD examples include:

Non-prescription drugs are not:

There are instances where the classification of a product is not immediately apparent. For example, "interface products" may meet elements of more than one definition. Common non-prescription drug interfaces include:

For more information on Health Canada's classification criteria and other products:

Page details

2026-03-30